Q4 2022 InMed Pharmaceuticals Inc Earnings Call Transcript

Sep 23, 2022 / 05:00PM GMT
Operator

Good day and thank you for standing by. Welcome to the InMed Pharmaceuticals' fourth-quarter fiscal 2022 financial results and business update conference call. (Operator Instructions)

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Colin Clancy, Vice President of Investor Relations.

Colin Clancy - InMed Pharmaceuticals Inc. - VP of IR

Thank you, Norma, and good day, ladies and gentlemen. My name is Colin Clancy, InMed's Vice President of Investor Relations. Welcome to InMed's fiscal year and 2022 financial results and business update conference call.

Please note our speakers are joining today from remote locations, so we appreciate your patience if we encounter any unexpected technical challenges.

Before we begin, we would like to go over our disclosure statements, followed by a progress report on our pharmaceutical drug development program, led by our President and CEO, Eric Adams, together with an update on our health and wellness commercial activities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot